David Apelian

David Apelian

Amministratore Delegato presso
Theolytics Ltd.
61 anni
Health Technology
Consumer Services

Profilo

David Apelian is currently Chief Executive Officer at Theolytics Ltd. since 2024.
Formerly, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. from 2022 to 2024, Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013, Clinical Director-Infectious Diseases Group at Bristol Myers Squibb Co. from 2002 to 2004, Clinical Director-Hepatology Department at Schering-Plough Corp.
from 1999 to 2002, and Vice President at Wyeth Pharmaceuticals LLC.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA from Quinnipiac University.

Posizioni attive di David Apelian

SocietàPosizioneInizio
Amministratore Delegato 17/12/2024

Precedenti posizioni note di David Apelian

SocietàPosizioneFine
EIGER BIOPHARMACEUTICALS Amministratore Delegato 01/09/2024
Amministratore Delegato 04/10/2022
ACHILLION PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 28/12/2017
GLOBEIMMUNE, INC. Direttore Tecnico/Scientifico/R&S 01/01/2013
BRISTOL-MYERS SQUIBB COMPANY Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di David Apelian

Formazione di David Apelian

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

63

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. David Apelian